During the past decade, Hospital de Mollet conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital de Mollet" are "Breakthrough Pain" (1 trials), "COVID-19" (1 trials), "Chronic Renal Failure" (1 trials), "SARS-CoV-2 Acute Respiratory Disease" (1 trials) and "Stroke, Acute" (1 trials). Many other conditions were trialed in "Hospital de Mollet" in a lesser frequency.

Most popular intervention types in "Hospital de Mollet" are "Other" (2 trials), "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "COVID-19 Vaccine 40 ug/dose" (1 trials), "No intervention" (1 trials), "Non-interventional study" (1 trials) and "Simvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Mollet" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hospital de Mollet". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital de Mollet, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Mollet, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".